This brand name is authorized in Poland
The drug ASPAR contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Magnesium hydrogen aspartate
UNII 082H981FMA - MAGNESIUM ASPARTATE ANHYDROUS
|
|
Magnesium is a cofactor in >300 enzymatic reactions. It acts as an essential co-factor for all ATP-binding enzymes. Magnesium plays an important role in cellular electrolyte homeostasis and in the neuromuscular membrane stabilization. |
|
2
Potassium hydrogen aspartate
UNII E9VW2509NH - POTASSIUM ASPARTATE ANHYDROUS
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A12CX | Other mineral products | A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100246459 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
